In Japan, CDx devices are used in clinical trials to identify suitable patients for targeted therapies. These tests predict the response to a specific treatment based on genetic markers. The results help in selecting the patient cohort, enhancing the trial’s efficiency, and increasing the likelihood of successful outcomes. CDx’s that are outlined in the clinical trial application can be used in Japan prior to approval.
